CalciMedica CALC Q4 2025 Disappoints EPS 073 Below 042 Views Innovative ISSC Crushes Q1 2026 Estimates EPS 026 Tops Views Centurion Wt ALFUW Stock Consolidating at 012 Next Move Ahead 20260515 US Monthly Retail Trade Report Released Key Insights into Consumer Spending Trends Cross Timbers Royalty Trust CRT Holds Near Support After Recent Decline Geopolitical Tensions Rise as Israeli Ministers Actions Draw International Condemnation Voyager Therapeutics VYGR Q1 2026 Earnings Why the Beat Matters Adobe ADBE Down 173 How Low Could It Go 20260520 Latin American Leaders at WUF13 Call for New Housing Finance Models and ClimateResilient Urban Development Salesforce Shares Dip as Soft Revenue Outlook Raises AI Disruption Concerns KeyBanc Maintains Overweight on Microsoft as Azure Copilot Momentum Builds Navigating CDs in Hospice A Familys Estate Planning Question Tech Strength Drives SP 500 Modest Gain Amid Sector Divergence Ferry Freight Costs Rise in Gorey Sparking Business and Housing Worries Sea Limited SE Q1 2026 Earnings EPS Misses Estimates as Gaming and ECommerce Face Headwinds NTIP Q1 2026 Earnings Net Loss of 002 Reported Stock Dips 067 Cresud CRESY Q1 2026 Earnings Strong EPS Report Despite Modest Stock Decline LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline Paranovus Entertainment Technology Ltd PAVS Q2 2022 Earnings Massive EPS Miss Highlights Severe Operational Challenges Former Prince Andrew Faces Expanded Police Investigation Potential Financial Repercussions VALE Q1 2026 Earnings EPS Falls Short of Estimates Amid Commodity Market Headwinds HURN Q1 2026 Earnings EPS Beats Estimates as Consulting Services Maintain Momentum BK Q1 2026 Earnings EPS Surpasses Estimates by 133 Revenue Details Not Disclosed ZION Q1 2026 Earnings EPS Surprise Beats Estimates Amid Cautious Banking Environment NAII Q2 2024 Earnings Loss Per Share of 052 Highlights Challenges Odysightai Q1 2026 Earnings EPS Misses Estimates Stock Declines CSWC Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Positive Sentiment Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development